Public signalCompany raiseAuto-indexed · Unverified
CASI Pharmaceuticals, Inc. raised $5.0M
CASI Pharmaceuticals, Inc.· BEIJING, CHINA· Pharmaceuticals· Filed Jan 28, 2026
CASI Pharmaceuticals, Inc. reported raising capital. Based in BEIJING, CHINA. First sale reported 2026-01-09. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$5.0M
Confidence90%
Raised
$5.0M
Investors
1
Incorporated
2023
Jurisdiction
CAYMAN ISLANDS
On the record
- Location
- BEIJING, CHINA
- Sector
- Pharmaceuticals
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $5.0M
- Target amount
- $5.0M
- Filing date
- Jan 28, 2026
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Filing details
- Jurisdiction of incorporation
- CAYMAN ISLANDS
- Year incorporated
- 2023
- Industry group
- Pharmaceuticals
- Number of investors
- 1
- Includes non-accredited investors
- No
- Revenue range
- $5,000,001 - $25,000,000
- Total offering amount
- $5.0M
- Amendment
- No
People named on this filing
Officers, directors, managers and entities listed in the public filing.
Alexander A. Zukiwski
Executive Officer
South San Francisco, US
Alexander Y. Wu
Director
Rockville, US
Barbara Krebs-Pohl
Director
South San Francisco, US
Chunhua Wang
Executive Officer
Beijing, CHINA
David Cory
Executive Officer
South San Francisco, US
Hai Huang
Executive Officer
Beijing, CHINA
James Huang
Director
South San Francisco, US
Kun Qian
Executive Officer
Beijing, CHINA
Thomas Folinsbee
Director
Beijing, CHINA
Wei (Larry) Zhang
Executive Officer
South San Francisco, US
Wei Gao
Executive Officer
Beijing, CHINA
Wei-Wu He
Director
Beijing, CHINA
Xuebo Zeng
Director
Beijing, CHINA
Zhenbo Su
Director
Beijing, CHINA
Sources & provenance
“Operating company sold 5,000,000 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Jan 28, 2026. Details beyond the filing have not been verified.
Tags
CHINACompanyPharmaceuticals$1M – $10MCompany Raise
Are you associated with CASI Pharmaceuticals, Inc.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record